Pages that link to "Q28330935"

The following pages link to Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X (Q28330935):

Displaying 46 items.

• The effect of recombinant aminopeptidase A (APA) on hypertension in pregnant spontaneously hypertensive rats (SHRs) (Q24315276) (← links)
• Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease (Q26748814) (← links)
• Angiotensin II is involved in nitric oxide synthase and cyclo-oxygenase inhibition-induced leukocyte-endothelial cell interactions in vivo (Q28346472) (← links)
• The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats (Q28369423) (← links)
• In vivo evidence that isoproterenol may increase heart rate in the rat by mechanisms in addition to activation of cardiac beta(1)- or beta(2)-adrenoceptors (Q28376248) (← links)
• Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype (Q28378367) (← links)
• Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers (Q34347645) (← links)
• Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats (Q34481753) (← links)
• Could the pharmacological differences observed between angiotensin II antagonists and inhibitors of angiotensin converting enzyme be clinically beneficial? (Q35555745) (← links)
• Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass (Q35821338) (← links)
• AT(1)-receptor blockade and sympathetic neurotransmission in cardiovascular disease (Q35837657) (← links)
• Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats. (Q35873111) (← links)
• A pharmacodynamic study of SR 47436, a selective AT1 receptor antagonist, on blood pressure in conscious cynomolgus monkeys (Q35874306) (← links)
• Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat. (Q35884801) (← links)
• New insights into the role of aminopeptidases in the treatment for both preeclampsia and preterm labor (Q38127847) (← links)
• Renal Vascular Responses to Angiotensin II in Conscious Spontaneously Hypertensive and Normotensive Rats (Q39469825) (← links)
• The clinical potential of renin inhibitors and angiotensin antagonists (Q40390189) (← links)
• Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy (Q40811095) (← links)
• New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitors (Q40813465) (← links)
• Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension (Q40940040) (← links)
• Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats (Q41857844) (← links)
• Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans (Q42084127) (← links)
• Alterations of cyclo-oxygenase products and NO in responses to angiotensin II of resistance arteries from the spontaneously hypertensive rat. (Q42581842) (← links)
• Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats (Q42702738) (← links)
• Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats (Q42714643) (← links)
• Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension (Q44225009) (← links)
• Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats (Q44316799) (← links)
• Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats (Q44390736) (← links)
• Endogenous angiotensin II has fewer effects but neuronal nitric oxide synthase has excitatory effects on renal sympathetic nerve activity in salt-sensitive hypertension-induced heart failure. (Q46064511) (← links)
• The effect of acute angiotensin II blockade on renal function in rats with reduced renal mass. (Q46695297) (← links)
• Synergistic Effects of ACE Inhibition and Ang II Antagonism on Blood Pressure, Cardiac Weight, and Renin in Spontaneously Hypertensive Rats (Q47298474) (← links)
• Parallel regulation of arginine transport and nitric oxide synthesis by angiotensin II in vascular smooth muscle cells role of protein kinase C. (Q47731884) (← links)
• Pharmacologic Profiles of KRH-863, a Novel Nonpeptide Angiotensin II-Receptor Antagonist (Q48590936) (← links)
• Angiotensin II receptor subtypes in rat brain: dithiothreitol inhibits ligand binding to All-1 and enhances binding to All-2 (Q48739688) (← links)
• Effects of losartan on short-term variability of blood pressure in SHR and WKY rats (Q52359292) (← links)
• Role of the renin-angiotensin system in systemic and regional vascular responses to orthostatic stress in healthy volunteers. (Q54184088) (← links)
• Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs (Q67773801) (← links)
• The role of endogenous angiotensin II in the regulation of renal haemodynamics and proximal fluid reabsorption in the rat (Q67965232) (← links)
• In vitro pharmacological characterization of UP 269‐6, a novel nonpeptide angiotensin II receptor antagonist (Q71941300) (← links)
• Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models (Q72113785) (← links)
• Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy (Q73683739) (← links)
• Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs (Q73879610) (← links)
• Contribution of Nitric Oxide to the Acute Antihypertensive Effect of Blockers of AT1Angiotensin Receptors in Spontaneously Hypertensive Rats (Q73913217) (← links)
• AT 2 Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism (Q74132672) (← links)
• Influence of Nitric Oxide in the Chronic Phase of Two-Kidney, One Clip Renovascular Hypertension (Q74165893) (← links)
• High-sucrose diets in pregnancy alter angiotensin II-mediated pressor response and microvessel tone via the PKC/Cav1.2 pathway in rat offspring (Q87827333) (← links)